SCHEMBL23178104

SCHEMBL23178104

O=C(c1ccccc1)N1c2ccc3ccccc3c2C=CC1(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX4 Q99571 3/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CRHBP P24387 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ CRHR2 Q13324 1/20 0.36
▸ TSHR P16473 3/20 0.33
▸ USP2 O75604 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ ELANE P08246 1/20 0.33
▸ MAPT P10636 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ CTNNB1 P35222 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29613256 1.00 P2RX4 (0.40) P2RX4NPSR1CYP1A2CYP3A4CYP2C9
SCHEMBL29613253 0.86 MAPT (0.39) P2RX4NPSR1CYP1A2CYP3A4CYP2C9
SCHEMBL23178258 0.86 MAPT (0.39) P2RX4NPSR1CYP1A2CYP3A4CYP2C9
SCHEMBL29613266 0.67 HSD11B1 (0.39) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL23178110 0.67 HTT (0.35) P2RX4MEN1KMT2ATSHRMAPT
SCHEMBL29613271 0.67 HTT (0.35) P2RX4MEN1KMT2ATSHRMAPT
SCHEMBL23178256 0.67 HSD11B1 (0.39) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL23178101 0.66 HTT (0.34) P2RX4MEN1KMT2AMAPTRAB9A
SCHEMBL23178257 0.66 MAPT (0.35) P2RX4MEN1KMT2AMAPK1MAPT
SCHEMBL23178307 0.66 P2RX4 (0.33) P2RX4MEN1KMT2AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220333004-A1 Dihydroquinoline Photochromic Compounds TRANSITIONS OPTICAL, LTD. (IE) 2022-10-20 — — US disclosed
WO-2021058114-A1 DIHYDROQUINOLINE PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, LTD. (IE) 2021-04-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220333004-A1 Dihydroquinoline Photochromic Compounds CBR3, CBR1, RECQL P2RX4 1173/4885NPSR1 1634/4885CYP1A2 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback